
Inventum.AI helps pharma researchers design new drug molecules more efficiently. It uses end-to-end generative AI to model protein-ligand interactions and accelerate medicinal chemistry. The platform is a B2B drug discovery tool that leverages core AI-based molecular design and protein interaction modeling to support pharmaceutical and biotech teams. It aims to democratize access to drug discovery by broadening participation across organizations. The system focuses on speed, accuracy, and safety in early drug design and aims to improve the probability of clinical trial success.

Inventum.AI helps pharma researchers design new drug molecules more efficiently. It uses end-to-end generative AI to model protein-ligand interactions and accelerate medicinal chemistry. The platform is a B2B drug discovery tool that leverages core AI-based molecular design and protein interaction modeling to support pharmaceutical and biotech teams. It aims to democratize access to drug discovery by broadening participation across organizations. The system focuses on speed, accuracy, and safety in early drug design and aims to improve the probability of clinical trial success.